Tammy Furlong - 15 May 2025 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: ELEV
Reported as of: 15 May 2025
Net transaction value: -$235
SEC form: 4
Accepted by SEC: 19 May 2025, 16:15:05 UTC
Prior SEC filing: 19 Feb 2025
Next SEC filing: 24 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Robert Yang, Attorney-in-Fact

Key filing fact

Tammy Furlong filed Form 4 for Elevation Oncology, Inc. (ELEV) on 19 May 2025.

Key facts

This page summarizes Tammy Furlong's Form 4 filing for Elevation Oncology, Inc. (ELEV).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 May 2025, 16:15.

Change

Previous filing in this sequence was filed on 19 Feb 2025.
Current net transaction value: -$235.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001984204 Primary reporting owner

Furlong Tammy

Relationship: CHIEF FINANCIAL OFFICER
Address: C/O ELEVATION ONCOLOGY, INC., 101 FEDERAL STREET, SUITE 1900, BOSTON
Signature: /s/ Robert Yang, Attorney-in-Fact
Signature date: 19 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELEV transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,643
Change %: +32%
Price
Shares after: 10,859
Date: 15 May 2025
Ownership: Direct
Footnotes: F1

ELEV transaction

Common Stock

Tax liability

Transaction value: $235
Shares: -784
Change %: -7.2%
Price: $0.2998
Shares after: 10,075
Date: 15 May 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELEV transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -2,343
Change %: -8.3%
Price: $0.000000
Shares after: 25,782
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,343
Exercise price
Footnotes: F1, F2, F3

ELEV transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -300
Change %: -12%
Price: $0.000000
Shares after: 2,100
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 300
Exercise price
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Footnote F3

The RSUs do not expire; they either vest or are canceled prior to the vesting date.

Footnote F4

25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.